Concentra Group Holdings Parent, Inc. (CON) AI Stock Analysis

• Market Cap: $3.02B
• Dividend Yield: 1.27%
• Average Volume (3M): 732.23K
• Price to Earnings (P/E): 18.1
• Beta (1Y): 0.49
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 8,758
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Equipment & Services
• EPS (TTM): N/A
• Shares Outstanding: 128,170,200
• 10 Day Avg. Volume: 831,607
• 30 Day Avg. Volume: 732,227
• PEG Ratio: -1.80
• Price to Book (P/B): 9.19
• Price to Sales (P/S): 1.33
• P/FCF Ratio: 12.05
• Enterprise Value/Market Cap: 1.70
• Enterprise Value/Revenue: 2.46
• Enterprise Value/Gross Profit: 8.66
• Enterprise Value/Ebitda: 13.04
• 1Y Price Target: $27.67
• Price Target Upside: 17.54% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 70 Outperform
• Price Target: $24.00 ▲(1.95% Upside)

The score is driven most by solid but mixed financial performance (growth and improved leverage, offset by declining margins and negative free-cash-flow growth). Technicals add support with a clear uptrend and positive momentum. Recent earnings commentary is a net positive due to raised guidance and strong operating metrics, while valuation is reasonable but not especially cheap and the dividend is modest.

Positive Factors

Revenue Growth

Strong revenue growth indicates successful market expansion and product adoption, enhancing the company's competitive position.

Strategic Acquisitions

Effective acquisition integration demonstrates the company's ability to enhance operational efficiencies and synergies, driving long-term growth.

Leadership in Data and AI

Strengthening leadership in data and AI aligns with growth priorities, potentially enhancing innovation and operational efficiency.

Negative Factors

Declining Profit Margins

Decreasing profit margins indicate potential challenges in cost management, which could impact long-term profitability.

Negative Free Cash Flow Growth

Negative free cash flow growth suggests potential cash flow challenges, which could limit financial flexibility and investment capacity.

Increased Administrative Expenses

Rising administrative expenses may strain profitability, requiring improved cost control to sustain long-term financial health.

Concentra Group Holdings Parent, Inc. Business Overview & Revenue Model

Company Description

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.

How the Company Makes Money

Concentra Group Holdings Parent, Inc. generates revenue through several key streams, primarily by owning and operating subsidiary companies in its diversified portfolio. These subsidiaries contribute to the company's earnings by providing products and services in their respective markets, such as technology solutions, real estate investments, and financial services. The revenue model includes direct sales from products, service contracts, and leasing income from real estate holdings. Additionally, strategic partnerships with other firms in complementary sectors help expand market reach and generate additional income through collaborative projects and joint ventures. The company's ability to leverage its resources and expertise across its sectors enhances profitability and positions it for long-term growth.

Concentra Group Holdings Parent, Inc. Financial Statement Overview

Summary

Financial statements show steady revenue growth and improved leverage (debt-to-equity improved to 1.39), but profitability is weakening (net margin down to 7.33% and lower EBIT/EBITDA margins) and free cash flow growth is negative (-6.07%). Cash conversion remains solid (operating cash flow to net income at 0.81; FCF to net income at 0.69), but the trend points to execution risk on cash flow.

Income Statement

Concentra Group Holdings Parent, Inc. has shown consistent revenue growth with a TTM growth rate of 4.15%. The gross profit margin has improved slightly to 28.36% in the TTM, indicating better cost management. However, the net profit margin has decreased to 7.33% from 8.76% in the previous year, reflecting a decline in profitability. The EBIT and EBITDA margins have also decreased, suggesting potential challenges in operational efficiency.

Balance Sheet

The company's debt-to-equity ratio has improved significantly in the TTM to 1.39 from a high of 7.08 in the previous year, indicating better leverage management. However, the return on equity has decreased to 46.76% from 60.41%, which could be a concern for investors. The equity ratio remains stable, suggesting a balanced asset structure.

Cash Flow

The operating cash flow to net income ratio is strong at 0.81, indicating good cash generation relative to net income. However, the free cash flow growth rate is negative at -6.07%, which could signal potential cash flow challenges. The free cash flow to net income ratio remains healthy at 0.69, showing that the company is still generating adequate free cash flow relative to its net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	2.09B	1.90B	1.84B	1.72B
Gross Profit	592.56M	527.98M	512.43M	408.19M
EBITDA	393.68M	368.26M	360.15M	330.20M
Net Income	153.24M	166.54M	179.95M	166.73M
Balance Sheet
Total Assets	2.84B	2.52B	2.49B	2.30B
Cash, Cash Equivalents and Short-Term Investments	49.94M	183.25M	31.37M	37.66M
Total Debt	2.14B	1.95B	905.00M	1.04B
Total Liabilities	2.43B	2.22B	1.31B	1.30B
Stockholders Equity	385.49M	275.67M	1.16B	973.32M
Cash Flow
Free Cash Flow	175.56M	210.35M	164.98M	228.35M
Operating Cash Flow	254.42M	274.68M	234.32M	274.34M
Investing Cash Flow	-411.41M	-71.27M	-75.31M	-57.75M
Financing Cash Flow	70.11M	-51.53M	-165.29M	-209.86M

Concentra Group Holdings Parent, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 23.54
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CON, the sentiment is Positive. The current price of 23.54 is above the 20-day moving average (MA) of 22.67, above the 50-day MA of 21.01, and above the 200-day MA of 20.95, indicating a bullish trend. The MACD of 0.83 indicates Negative momentum. The RSI at 65.61 is Neutral, neither overbought nor oversold. The STOCH value of 59.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CON.

Concentra Group Holdings Parent, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FLOC	71 Outperform	$1.96B	42.38	―	1.32%	―	―
CON	70 Outperform	$3.02B	18.11	46.21%	1.27%	―	―
LH	70 Outperform	$23.43B	27.76	10.51%	1.14%	8.28%	97.24%
NVST	61 Neutral	$4.75B	105.38	1.56%	―	4.73%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
BBNX	47 Neutral	$613.70M	-7.78	-47.52%	―	67.01%	-39.19%
SPAI	39 Underperform	$81.59M	-4.97	-193.70%	―	―	―

Concentra Group Holdings Parent, Inc. Corporate Events

Concentra Posts Strong Q4 Results and Raises 2026 Outlook

On January 28, 2026, Concentra announced preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, showing that it exceeded its prior full-year guidance and extended its lead in the U.S. occupational health market. Fourth-quarter 2025 revenue rose 15.9% year over year to $539.1 million, net income climbed 58.7% to $36.2 million, and adjusted EBITDA increased 22.9% to $95.3 million, driven by a 9% rise in daily patient visits, higher revenue per visit, significant expansion to 628 occupational health centers and 411 onsite clinics, and continued share repurchases. For full-year 2025, Concentra expects revenue of $2.16 billion, up 13.9% from 2024, adjusted EBITDA of $431.9 million, higher revenue per visit, free cash flow of $197.8 million, and a net leverage ratio of about 3.4x, underpinned by increased capital expenditures to support rapid network growth. The company also issued 2026 guidance calling for further gains, with revenue projected between $2.25 billion and $2.35 billion, adjusted EBITDA of $450 million to $470 million, free cash flow of $200 million to $225 million, and lower leverage of 3.0x or below, and scheduled the release of full 2025 results for February 26, 2026, followed by an earnings call on February 27, 2026; alongside the numbers, Concentra published its first Investor Book to deepen market understanding of its business model and growth strategy, signaling confidence in sustained expansion and an effort to reinforce its positioning with investors and other stakeholders.

The most recent analyst rating on (CON) stock is a Hold with a $22.00 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.

Concentra Showcases Growth and Scale at Healthcare Conference

In an investor presentation prepared for the J.P. Morgan Healthcare Conference in January 2026, Concentra highlighted its position as the dominant U.S. occupational health provider, treating about one in four workplace injuries and operating more than 1,000 locations with multiple delivery channels. As of the twelve months ended September 30, 2025, the company reported $2.1 billion in revenue, a 19.8% adjusted EBITDA margin and $176 million in free cash flow, underpinned by largely inflation‑tracking fee‑for‑service pricing, minimal exposure to government reimbursement risk and long‑tenured direct relationships with major employers. Management emphasized the use of non‑GAAP metrics such as Adjusted EBITDA, Adjusted Net Income, ROIC and Free Cash Flow to evaluate segment performance and allocate resources, framing Concentra’s scale, diversified customer base and lower cost per claim as key competitive advantages for investors and employer stakeholders.

The most recent analyst rating on (CON) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.

Concentra Awards Restricted Shares to Executives

On November 4, 2025, Concentra Group Holdings Parent, Inc. awarded restricted shares of its common stock to its named executive officers under the 2024 Equity Incentive Plan. The shares will vest equally over four years, impacting the compensation structure and potentially aligning executive interests with company performance.

The most recent analyst rating on (CON) stock is a Buy with a $29.00 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.

Concentra Group Reports Strong Q3 2025 Financial Results

Concentra Group Holdings Parent, Inc. announced its third-quarter 2025 financial results, reporting a 17% increase in revenue to $572.8 million and an 8.9% rise in net income to $49.8 million compared to the same period in 2024. The company declared a cash dividend of $0.0625 per share and authorized a $100 million share repurchase program. These moves, alongside strong financial performance and strategic initiatives, position Concentra to enhance its market presence and deliver improved outcomes for stakeholders.

The most recent analyst rating on (CON) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.